NK cell alloreactivity and allogeneic hematopoietic stem cell transplantation
- 26 October 2007
- journal article
- Published by Elsevier in Blood Cells, Molecules, and Diseases
- Vol. 40 (1), 84-90
- https://doi.org/10.1016/j.bcmd.2007.06.029
Abstract
No abstract availableKeywords
This publication has 41 references indexed in Scilit:
- Full Haplotype-Mismatched Hematopoietic Stem-Cell Transplantation: A Phase II Study in Patients With Acute Leukemia at High Risk of RelapseJournal of Clinical Oncology, 2005
- Effectiveness of Donor Natural Killer Cell Alloreactivity in Mismatched Hematopoietic TransplantsScience, 2002
- Treatment of High-Risk Acute Leukemia with T-Cell–Depleted Stem Cells from Related Donors with One Fully Mismatched HLA HaplotypeNew England Journal of Medicine, 1998
- Functionally and Structurally Distinct NK Cell Receptor Repertoires in the Peripheral Blood of Two Human DonorsImmunity, 1997
- Megadose of T cell-depleted bone marrow overcomes MHC barriers in sublethally irradiated miceNature Medicine, 1995
- P58 molecules as putative receptors for major histocompatibility complex (MHC) class I molecules in human natural killer (NK) cells. Anti-p58 antibodies reconstitute lysis of MHC class I-protected cells in NK clones displaying different specificities.The Journal of Experimental Medicine, 1993
- Generation of Allospecific Natural Killer Cells by Stimulation Across a Polymorphism of HLA-CScience, 1993
- Evidence of a natural killer (NK) cell repertoire for (allo) antigen recognition: definition of five distinct NK-determined allospecificities in humans.The Journal of Experimental Medicine, 1992
- In search of the ‘missing self’: MHC molecules and NK cell recognitionImmunology Today, 1990
- Selective rejection of H–2-deficient lymphoma variants suggests alternative immune defence strategyNature, 1986